Profile_bird

Hey there! ThePharmaLetter is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What's happening? Join today to start receiving ThePharmaLetter's tweets.

Already using Twitter
from your phone? Click here.

ThePharmaLetter

  1. Generic erosion will bite into the acute coronary syndrome market, cutting sales nearly 10% from 2008 to 2018 http://bit.ly/6RLKRG #pharma about 14 hours ago from Mixero
  2. Anesiva shareholders agree to Arcion takeover http://bit.ly/7tHcm1 #pharma about 14 hours ago from Mixero
  3. Valeant to acquire Laboratoire Dr Renaud of Canada in $21.8 million deal http://bit.ly/7Wk9dj #pharma about 14 hours ago from Mixero
  4. Struggling La Jolla Pharma saved by merger with Adamis http://bit.ly/8ho6ra #pharma about 14 hours ago from Mixero
  5. USA’s Budget Office reviews promotional spending for prescription drugs http://bit.ly/6hDy7H #pharma about 15 hours ago from Mixero
  6. Improved overall survival in most common leukemia treated with Roche’s MabThera http://bit.ly/54qzaf #pharma about 15 hours ago from Mixero
  7. USA’s already $232 billion personalized medicine market to grow 11% a year, says PricewaterhouseCoopers http://bit.ly/4A0tAh #pharma about 15 hours ago from Mixero
  8. Nippon Chemiphar to take full control of Japanese JV with Ranbaxy http://bit.ly/7AcoVE #pharma about 15 hours ago from Mixero
  9. Celgene buys rival Gloucester for $640 million, gaining rights to Istodax; Allos defends price of Folotyn http://bit.ly/8X2VCf #pharma about 15 hours ago from Mixero
  10. EU achieves political breakthrough on an enhanced patent system http://bit.ly/5dFwgP #pharma about 15 hours ago from Mixero
  11. happy weekend all! #pharma 10:10 AM Dec 4th from Mixero
  12. Indonesia’s Rx and OTC drugs market to grow to $7.8 billion in 2019 http://bit.ly/8k49gG #pharma 10:10 AM Dec 4th from Mixero
  13. Australian pharma industry embraces tougher Code of Conduct http://bit.ly/5RRCaH #pharma 10:09 AM Dec 4th from Mixero
  14. Mexico City to build world-class hub for medical research http://bit.ly/8OzGPG #pharma 10:09 AM Dec 4th from Mixero
  15. Watson buy of Arrow requires product divestments, says USA’s FTC http://bit.ly/7CiliV #pharma 10:08 AM Dec 4th from Mixero
  16. US FDA approves AstraZeneca’s Seroquel XR for add-on treatment of MMD and standard drug for pediatric use http://bit.ly/7cPE8G #pharma 10:08 AM Dec 4th from Mixero
  17. European MS patients still face inequities in access to innovative treatments http://bit.ly/5SVS7a #pharma #ms 10:07 AM Dec 4th from Mixero
  18. Biogen Idec ups offer 21% for Facet Biotech to $17.50 a share, which is again rejected by board http://bit.ly/4wdeVc #pharma #biotech 10:06 AM Dec 4th from Mixero
  19. Roche/Ipsen’s taspoglutide meets Ph III endpoints, beating Merck & Co’s Januvia http://bit.ly/5E0y8t #pharma 10:06 AM Dec 4th from Mixero
  20. USA’s Public Citizen again calls for a ban on Abbott’s obesity drug Meridia http://bit.ly/7cvVQH #pharma 10:05 AM Dec 4th from Mixero
  • Name ThePharmaLetter
  • Location London
  • Web http://www.thepha...
  • Bio Up to date news for the Pharmaceutical and Biotechnology industries
203 Following 291 Followers 21 Listed
Lift Conference jean-francois delas Sentropy, Inc. Nextrials Bay Area Bioscience ThotWave LifeScience WSJ Health Blog BioData Ocimum - Gene Logic ed silverman Jim Edwards srcomblog Hubert Ludwiczak Silja Megan Krystle Ficco megan blickley joelrobitaille danielle loosbrock BioPharmLaura Sean Griffey Mark Uehling BioSpace Rich Meyer Scott Hensley GeneRef Jonathan Betts PharmaNewsNow Boehringer Akaza Research LLC RAJPharma.com Sam Walmsley Chris Morrison pharmatweetical Mike Auerbach Scripnews.com